Actelion selects IntraLinks to streamline clinical trial info exchange

Tuesday, September 25, 2012 03:06 PM

Actelion Pharmaceuticals, a Switzerland-based biopharmaceutical company that focuses treatments to serve unmet medical needs, has selected IntraLinks, a global technology provider of inter-enterprise content management and collaboration solutions, to streamline their documentation exchange during clinical trials.

“Actelion’s engagement of IntraLinks demonstrates the growing demand for secure information exchange within the clinical trial process,” said Andy Watson, vice president of life sciences EMEA at IntraLinks. “IntraLinks Connect will provide Actelion greater efficiency, traceability, and security to improve communication, collaboration and document exchange between everyone involved in the clinical trial.”

Prior to engaging IntraLinks, Actelion relied on traditional courier services to facilitate the exchange of sensitive clinical trial documentation between sponsors and participants, resulting in excessive shipping costs and manual processes for tracking and other activities.

To streamline their documentation process and gain efficiency for themselves and their investigators, Actelion chose IntraLinks Connect to provide central clinical trial portals to facilitate the more secure, compliant auditable exchange of site feasibility, study start up, study conduct and study close-out documentation.

IntraLinks Connect’s security, detailed reporting, workflows and analytics, together with IntraLinks’ knowledgeable professional service support convinced Actelion that IntraLinks provided the best fit to their requirements.

“Whilst working with IntraLinks we can see the maturity of their technology and the commitment of the team to support Actelion moving forward in this area,” said Christine Schwenninger, head of global clinical monitoring, Actelion. “We are looking forward to working closely together with IntraLinks in the coming years.”

Share:          
CWWeekly

April 27

Doctors, patients in the U.S. and U.K. agree: Mobile health apps are good for our health

AARP teams with Georgia Tech's HomeLab, Pfizer and UnitedHealthcare to test wearables with consumers 50+

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs